Skip to content
OpenCapital
Get started

Pacific Biosciences of California PACB Investment Purchases

Investment Purchases at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$14M-94.7%
Twist Bioscience Corporation logo
Twist Bioscience CorporationTWST
$4.72M-4.3%
Personalis, Inc. logo
Personalis, Inc.PSNL
$67.04M+4.3%
10x Genomics, Inc. logo
10x Genomics, Inc.TXG
$24.71M—
Azenta logo
AzentaAZTA
$220.14M+12.6%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$226.1M+47.4%

Other financials

Income statement

See full
Revenue$37.2M+0.1%
Gross profit$12.8M+1,037%
Operating income-$8.4M+98.1%
Net income-$8.3M+98.1%
EPS (diluted)-$0.03+97.9%

Balance sheet

See full
Cash & equivalents$57.9M-4.7%
Total debt$59.3M+12.1%
Total equity$2.4M-97.4%
Total assets$782.4M-9.1%

Cash flow

See full
Operating cash flow-$44.7M-1.4%
CapEx$3.0M+119%
Free cash flow-$47.7M-5.0%

Valuation

See full
Market cap$496.96M+30.4%
Enterprise value$498.38M+33.5%
P/S3.1×+0.6×

Profitability

See full
Gross margin37.5%+21.3pp
Operating margin-83.3%-38.2pp
Net margin-80.3%-36.1pp
FCF margin-72.6%-20.0pp

Returns & leverage

See full
Return on equity-273.6%+314pp
Debt / equity25.1×+24.5×
Current ratio5.7×-1.0×

Where this comes from

Reported directly by Pacific Biosciences of California in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireInvestments.

The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pacific Biosciences of California's investment purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pacific Biosciences of California's investment purchases?
Pacific Biosciences of California (PACB) reported investment purchases of $52.45M in Q1 2026.
How has Pacific Biosciences of California's investment purchases changed year-over-year?
Pacific Biosciences of California's investment purchases decreased by 15.2% year-over-year, from $61.82M to $52.45M.
What is the long-term trend for Pacific Biosciences of California's investment purchases?
Over 4 years (2021 to 2025), Pacific Biosciences of California's investment purchases has grown at a -31.5% compound annual growth rate (CAGR), from $988.05M to $216.91M.
What does investment purchases mean?
Cash spent purchasing investment securities across all categories.